Navigation Links
fits in Medical Technology

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

...a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of the hand), light weight, and battery use, products incorporating eFlow Technology reduce the burden of taking daily, inhaled treatments...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

...a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, products incorporating eFlow Technology reduce the burden of taking daily, inhaled treatment...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

...a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, products incorporating eFlow Technology reduce the burden of taking daily, inhaled treatment...

Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient

... HOUSTON, May 18 /PRNewswire-USNewswire/ -- When treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual's risk for cardiovascular disease Saturday at the American Association of Clinical Endo...

Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy

... $12 billion per year. ToleroMune technology has additional potential regulatory and supply benefits for Circassia. Its state-of-the-art manufacturing fits with changes in the European regulatory environment, where authorities are increasingly treating allergen immunotherapies as pharmaceutical products, ...

Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients

... the condition. ToleroMune technology has additional potential regulatory and supply benefits for Circassia. Its state-of-the-art manufacturing fits with changes in the European regulatory environment, where authorities are increasingly treating allergen immunotherapies as pharmaceutical products, ...

Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis

...d lead author of the study. "However, it is also exciting to have interim results that indicate the use of Clobex Spray followed by Vectical Ointment fits well within accepted and common psoriasis treatment regimens." "These study results reinforce our commitment to bringing safe and effective thera...

Beating Blood Clots after Joint Replacement

...spital, in Charleston, SC. "The type of prophylaxis a patient may receive is often tailored on an individual basis, so there is not always a 'one-size fits all method' of prophylaxis available." More than 700,000 primary total hip and knee replacements are performed each year in the Uni...

Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease

...R Cysteamine in patients with Huntington's Disease. Our formation work with DR Cysteamine in conjunction with the CHU d'Angers studies in Huntington's fits our strategic plan to explore multiple potential indications for cysteamine and DR Cysteamine. Cysteamine has demonstrated neuroprotective effects in ...

VAI Finding Could Lead to New Drugs for Anxiety, Depression

... binds to CRF and other proteins in the same family. This detailed structural information can help drug developers engineer a drug that more perfectly fits to the receptor, making the drug more potent. Researchers determined the structure of the receptor in three different scenarios -- one with nothing bo...

In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices

...Spencer, Director of Support Services at The Center for Hospice and Palliative Care in South Bend, IN. "We feel what we are doing as a Hospice program fits into our philosophy for life and we are able to do that because of our success locally and participation at the national level. We believe it is time ...

APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism

... of stress on the lower back, especially for people who have pre-existing back problems. If you have brought along hand luggage or a rolling case that fits under the seat, use them as foot rests to elevate your feet so that your knees are slightly higher than your hips when you are sitting," suggests Moff...

Novel Photoconductive Life Science Research Innovation Enables Rapid, Reproducible, and Non-Invasive Cellular Excitation

..., where such experimental capabilities would be desirable. The PSD system controller is a fully contained, easy to use electronics base that readily fits into any bench-top environment. Cells for experimentation are grown on the silicon PSD substrates that fit in industry standard 24 well plates for cel...

Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent

...he first quickly accessible product to treat HAE patients offered in a convenient pre-filled syringe for subcutaneous administration. FIRAZYR not only fits our HGT portfolio but also leverages our capabilities of building successful global products for rare diseases." Prof. Dr. Jens Schneider-Mergener, ...

Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy

...n in the United States and in the European Union. Sylvie Gregoire, President of Shire's Human Genetic Therapies business, commented: "This product fits very well with Shire's ERT portfolio of treatments for Lysosomal Storage Disorders (LSD). Shire HGT has been committed to MLD and by acquiring this mi...

PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study

...a high proportion of respirable droplets delivered in the shortest possible amount of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, eFlow helps reduce the burden of taking daily inhaled treatments. About PARI Pharma PARI...

Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

...oundation to sign up for participation in the Registry program. If they consent, then they are notified by the Foundation if a current or future trial fits their specific disease indications. Matthew Alsante, Executive Director, Sarcoma Foundation of America, states, "The collaboration allows for a superi...

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

...a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, eFlow helps reduce the burden of taking daily, inhaled treatments. Aztreonam lysine for in...

MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera

... is a unique opportunity for MacroChem to broaden its product portfolio with a product that has already completed two Phase 3 clinical trials and that fits our strategic focus and complements our lead product candidate, EcoNail(R) for treatment of nail fungus," stated Robert J. DeLuccia, President and CEO...

Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products

...like to see the data replicated in other studies, but this is the type of study we must do if we are going to guide people to healthier nutrition that fits with their genetics." To view the published paper please visit http://nutritionjrnl.com/inpress For more information on Interleukin please visit ...

Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery

...a. "We are thrilled to be able to offer these cutting edge procedures to patients at our facility. It allows us to find the treatment option that best fits each individual patient, and we are able to successfully treat the majority of our patients with conservative treatment modalities and identify those ...

CEL-SCI Corporation Releases Letter to Shareholders

...cked to overcome the very complex tumor defense mechanisms and the constant mutation of the tumor antigens cannot be addressed with a 'one key fits all' approach. 3) They act like specific parts of our immune system, when in reality we need a more complete immune approach (the whole army vs. ...

Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases

...lieve the innovative technology platform pioneered by Pacific Pharma may have substantial commercial potential in a number of therapeutic areas and it fits well with our existing core competencies in computational-based approaches to biomarker identification. Pacific Pharma has also generated novel compou...

Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007

...oundations in innovative combinations with new targeted therapies. "This is an exciting time in cancer research as we are moving away from 'one-size fits all' treatment," said Richard Gaynor, M.D., Lilly vice president, cancer research and global oncology platform leader. "Lilly's commitment to finding ...

PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin

...a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, eFlow helps reduce the burden of taking daily inhaled treatments. For additional information...

Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma

...yeloma toward becoming a chronic disease with long term survival achieved by using drugs in combination and in sequence. The VELCADE/DOXIL combination fits perfectly into this paradigm and offers an important and powerful new opportunity to extend and improve patients' lives." DOXIL is a specially (lipo...

Genetics Journal Thimerosal/Autism Study the 'Best Science Drug Company Money Can Buy'

... have been exposed to RhIg in utero than their non-ASD siblings," according to the SafeMinds analysis. NAA's Fournier points out that the RhIg study fits a recurring pattern for thimerosal research with drug company/researcher ties. Manipulation of data to reach a desired conclusion was seen in CDC stud...

Genzyme Announces Results of Clinical Trial of Hylastan

...ts of viscosupplementation to help manage OA knee pain. We will continue to analyze the findings from the hylastan study to determine how this product fits into our longer-range strategy, as we continue to invest in bringing innovation to this field." About Genzyme One of the world's leading biotechno...
Other Tags
(Date:8/27/2014)... (June, 2014) Outstanding basic research, a growing ... dedication to patient care have earned the Herbert ... Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 ... National Cancer Institute (NCI). The grant renews the ... Comprehensive Cancer Centers in New York City and ...
(Date:8/27/2014)... trans-fats have largely succeeded in sidelining the use ... for its potential contributions to Americans, health conditions. ... the best way to assuage the nation,s insatiable ... Chemical & Engineering News (C&EN), the weekly ... In the article, Stephen Ritter, a senior correspondent ...
(Date:8/27/2014)... to be associated with outcomes after the repair ... the patient, mechanism of injury, nerve injured, injury ... technique, and repair materials. However, despite numerous studies ... injuries, there is no agreement regarding the independent ... relationship of the predictors has not been quantified. ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4
(Date:8/27/2014)... Stoneham, MA (PRWEB) August 27, 2014 ... lockbox payment processing, today announced that it will exhibit ... New York's (IBANYS) 41st annual convention in ... the 9th. , The event will be held at ... number of exciting activities and entertainment options in addition ...
(Date:8/27/2014)... IQ Formulations , a leading manufacturer of ... of the Cystic Fibrosis Foundation. For an entire month ... led by TigerFitness.com in which 5 percent of the ... to the respected nonprofit organization. , Last year, ... Isla, a young girl fighting Cystic Fibrosis. The company ...
(Date:8/27/2014)... Melbourne, Australia (PRWEB) August 27, 2014 ... by erratic climatic conditions and fluctuations in global supply ... over the past five years. The industry derives a ... manufacturers are subject to global market dynamics, with supply ... as Brazil and India. A strong Australian dollar for ...
(Date:8/27/2014)... Beginning in September, K9 Dog Park will ... interactive, fun way for daycare dogs to learn and compete. ... Park Doggy Daycare clients who bring their dogs into the ... will be able to watch their dogs compete through K9 ... in D.O.G. will win prizes as will the trainers who ...
(Date:8/27/2014)... Lake City, Utah (PRWEB) August 27, 2014 ... of Wasatch Indoor Bike Park, Utah’s first indoor mountain bike ... assortment of mountain and park-style bikes in both adult and ... SCOTT Sports, who already operated a distribution warehouse in Ogden, ... to Salt Lake City. , “We are proud to be ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Contributes Sizeable Donation to Cystic Fibrosis Foundation 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 3Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 4Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2
Other Contents